Drawing for CYNOSURE

USPTO serial 90387474

CYNOSURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JACKSON, STEVEN W
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CYNOSURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Byer

David J. Byer K&L GATES LLPONE LINCOLN STREETSTATE STREET FINANCIAL CENTERBOSTON, MA 02111

Goods and services

ClassDescriptionStatusFirst use
005Medicated skin care preparations; Medicated skin and body topical lotions, moisturizers, gels, creams, ointments and oils for medical purposes; Medicated cosmetics; Acne treatment preparations; Acne Medications; Medicated sunscreen; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating sunburn and sun damage; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders, hyperhidrosis and wrinkles; Pharmaceutical skin lotions; Injectable dermal fillers; Injectable dermal fillers for filling wrinkles; Tissue augmenting gel for medical purposes; Medicated gel injected under the skin to smooth out wrinkles; Medicated gel injected into one or more of the epidermal skin layer, dermal skin layer, and below the dermal skin layer to smooth out wrinkles; Pharmaceutical preparations for the treatment of lines, wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations for use in augmentation of soft tissue, smoothing out wrinkles and fine lines, and contouring the face; Kits for medical purposes consisting of syringes sold filled with pharmaceutical preparations for soft tissue augmentation, smoothing out wrinkles and fine lines, and contouring the face; Vitamins; Dietary and nutritional supplements; Medicated skin care preparations made in whole or in part of natural ingredients; Medicated skin and body topical lotions, moisturizers, gels, creams, ointments and oils made in whole or in part of natural ingredients; Medicated cosmetics made in whole or in part of natural ingredients; medical plasters; dressings for wounds, burns, surgery scars, scars; dressings having one or more properties including gas permeability, moisture maintenance, antimicrobial, absorbent, occlusive, adherence, and debridement for wounds, burns, surgery scars, scars; materials, namely, cloth, fiber, non-woven fiber, woven fiber, non-adherent, foam, hydrogel, hydrofiber, hydrocolloid, alginate, collagen, transparent, and polymer for dressingsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 22, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 22, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 22, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 20, 2023EX3GSOU EXTENSION 3 GRANTED—
Sep 20, 2023EXT3SOU EXTENSION 3 FILED—
Sep 20, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2023NOACCORRECTED NOA E-MAILED—
Apr 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 25, 2023EX2GSOU EXTENSION 2 GRANTED—
Apr 25, 2023DPCCDIVISIONAL PROCESSING COMPLETE—
Apr 25, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 6, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 1, 2023EXT2SOU EXTENSION 2 FILED—
Feb 1, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Feb 1, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Feb 1, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 21, 2022EX1GSOU EXTENSION 1 GRANTED—
Sep 21, 2022EXT1SOU EXTENSION 1 FILED—
Sep 21, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 22, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 22, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Dec 22, 2021ALIEASSIGNED TO LIE—
Dec 22, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 22, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 22, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 15, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2021DOCKASSIGNED TO EXAMINER—
Feb 25, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance